Placenta: When the past informs our future
Comparing the genes expressed at the maternal-fetal interface in different species helps to pinpoint those that contribute to a healthy pregnancy by regulating the activity of the immune system.
- Department of Biological Sciences, Vanderbilt University, United States
Your belly button is the last reminder of arguably the most fascinating yet fleeting organ you ever had: the placenta. Simultaneously taking on the role of lungs, liver, gut and kidneys, this temporary structure develops during pregnancy to provide the fetus with oxygen and nutrients while also removing waste products (Burton and Fowden, 2015). The placenta also features the maternal-fetal interface, where the cells of the mother and the fetus work together to develop the structures and avenues of communication necessary for a successful pregnancy. Disrupting this process can result in complications such as preeclampsia or preterm birth, which affects around 15 million pregnancies worldwide every year (Blencowe et al., 2012; Erlebacher, 2013).
Yet, it is almost impossible to safely study the maternal-fetal interface during pregnancy: instead, researchers can turn to its evolutionary history. Indeed, how the interface came to be is inseparable from the way it operates and malfunctions today. In particular, comparing and contrasting this process across diverse species can highlight innovations in specific pathways or genes. Now, in eLife, Vincent Lynch and colleagues – including Mirna Marinić as first author, Katelyn Mika and Sravanthi Chigurupati – report on using this approach to identify the genes that the maternal-fetal interface needs to form and work properly in placental animals (Marinić et al., 2021).
Marinić et al. – who are based at the University of Buffalo, the University of Chicago and AbbVie – gathered gene expression data from the maternal side of the maternal-fetal interface from 28 species ranging from frogs to people. Of the 20,000 genes studied, just 149 had placental expression which, when mapped onto the evolutionary tree, suggested that these genes had started to be expressed at the maternal-fetal interface when placental structures first emerged.
One of the 149 genes, known as HAND2 (short for heart and neural crest derivatives-expressed protein 2), encodes a regulatory protein that contributes to the embryo getting implanted into the wall of the uterus (Mestre-Citrinovitz et al., 2015). However, it has also been associated with preterm birth, and could be important later on for a healthy pregnancy (Brockway et al., 2019).
To understand how HAND2 is involved in the later stages of pregnancy, Marinić et al. used short-tailed opossum data and human cell cultures to create a model for the role of this gene at the maternal-fetal interface. The experiments revealed that HAND2 regulates IL15, a gene that encodes a cytokine – a type of small signaling protein that helps to regulate the activity of the immune system. While it was once thought that the maternal immune system was turned down to accommodate the ‘foreign cells’ of a fetus, scientists now know that it actively helps to establish and maintain a healthy pregnancy (Racicot et al., 2014). In particular, the immune system may contribute to triggering the onset of birth.
Marinić et al. discovered that early in pregnancy, HAND2 is present at high levels at the maternal-fetal interface. In turn, this increases the local expression of IL15, which then recruits natural killer cells, a component of the immune system that shapes the maternal-fetal interface. As pregnancy progresses, the expression of HAND2 and IL15 decreases; this might aid in the correct timing of birth by reducing levels of natural killer cells at the interface (Figure 1C).
Figure 1
Studying evolution to understand the genes that shape the maternal-fetal interface.
(A) The expression of HAND2 (large red circles) was measured at the maternal-fetal interface across multiple placental and non-placental species. Marinić et al. then used ancestral reconstruction to infer that the expression of HAND2 (small red circles) at the maternal-fetal interface arose in the ancestor of all placental mammals (shown in purple). In the wallaby, the expression of HAND2 has a distinct evolutionary origin, which is most likely associated with other derived pregnancy traits in this species. (B) The placenta (fetal; purple) and uterine wall (maternal; gray) meet at the maternal-fetal interface, where nutrients and waste are exchanged, and communication systems are established. (C) During early pregnancy, HAND2 is highly expressed at the maternal-fetal interface: the resulting increase in IL15 expression leads to immune natural killer cells (NK cells) being recruited to the interface (top), where they help to shape the structure. As pregnancy progresses, decreased HAND2 and IL15 expression alters the recruitment of NK cells, which may have a role in determining when birth should start.
To help diagnose, treat and prevent pregnancy disorders, we must first understand the tightly choreographed ballet of cells and communication signals that sustains healthy gestation. Examining the differences in gene expression between humans and closely related species helps to uncover new elements of this careful dance. By looking back at our past, Marinić et al. work to prevent future preterm births.
References
-
The placenta: a multifaceted, transient organPhilosophical Transactions of the Royal Society B: Biological Sciences 370:20140066.https://doi.org/10.1098/rstb.2014.0066
-
Immunology of the maternal-fetal interfaceAnnual Review of Immunology 31:387–411.https://doi.org/10.1146/annurev-immunol-032712-100003
-
Understanding the complexity of the immune system during pregnancyAmerican Journal of Reproductive Immunology 72:107–116.https://doi.org/10.1111/aji.12289
Article and author information
Author details
Publication history
Copyright
© 2021, LaBella
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,052
- views
-
- 99
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Placenta: When the past informs our future
eLife 10:e67169.
https://doi.org/10.7554/eLife.67169
Further reading
-
- Evolutionary Biology
With the availability of high-quality full genome polymorphism (SNPs) data, it becomes feasible to study the past demographic and selective history of populations in exquisite detail. However, such inferences still suffer from a lack of statistical resolution for recent, for example bottlenecks, events, and/or for populations with small nucleotide diversity. Additional heritable (epi)genetic markers, such as indels, transposable elements, microsatellites, or cytosine methylation, may provide further, yet untapped, information on the recent past population history. We extend the Sequential Markovian Coalescent (SMC) framework to jointly use SNPs and other hyper-mutable markers. We are able to (1) improve the accuracy of demographic inference in recent times, (2) uncover past demographic events hidden to SNP-based inference methods, and (3) infer the hyper-mutable marker mutation rates under a finite site model. As a proof of principle, we focus on demographic inference in Arabidopsis thaliana using DNA methylation diversity data from 10 European natural accessions. We demonstrate that segregating single methylated polymorphisms (SMPs) satisfy the modeling assumptions of the SMC framework, while differentially methylated regions (DMRs) are not suitable as their length exceeds that of the genomic distance between two recombination events. Combining SNPs and SMPs while accounting for site- and region-level epimutation processes, we provide new estimates of the glacial age bottleneck and post-glacial population expansion of the European A. thaliana population. Our SMC framework readily accounts for a wide range of heritable genomic markers, thus paving the way for next-generation inference of evolutionary history by combining information from several genetic and epigenetic markers.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.
